Skip to content

Comparision of adition of Fentanyl and Ketamin to 5/1% lidocaine with paracervical block in reducing of post operative pain in curettage

Comparision of adition of Fentanyl and Ketamin to 5/1% lidocaine with paracervical block in reducing of post operative pain in curettage

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201305204686N7
Enrollment
120
Registered
2013-05-24
Start date
2013-03-11
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

local anaesthesia. agents primarily acting on smooth and skeletal muscles and the respiratory system

Interventions

Intervention 1: First group(40 persons) receive lidocaine 1/5% 5cc plus fentanyl 100mg. Intervention 2: Second group (40 persons) receive lidocaine 1/5% 5cc plus ketamin 50mg. Intervention 3: Third gr
Treatment - Drugs
Placebo
First group(40 persons) receive lidocaine 1/5% 5cc plus fentanyl 100mg
Second group (40 persons) receive lidocaine 1/5% 5cc plus ketamin 50mg
Third group (40 persons) lidocaine 1/5% 5cc plus placebo 2cc

Sponsors

Arak University of Medival Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patient candidate curettage; age 20-45 years old; informed written consent for paracervical block. Exclusion criteria: prolonged procedure >20 minutes; failure of block and need to general analgesia; allergy to analgesic substances occurring of any heart diseases.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 30 and 60 minutes after intervention. Method of measurement: Clinical examination.

Secondary

MeasureTime frame
Drug side effects. Timepoint: 30 and 60 minutes after intervention. Method of measurement: Clinical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMehri Jamilian

Arak University of Medical Sciences

mjamilian@arakmu.ac.ir+98 86 1278 0660

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026